Merck Animal Health to Acquire Harrisvaccines
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/25/2026
- Nasdaq, S&P end lower as tech stocks fall
- Micron posts record profit as AI memory demand fuels explosive growth
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
Merck (MRK) Animal Health Enters Agreement to Acquire Harrisvaccines
November 12, 2015 5:06 PM ESTMerck (NYSE: MRK) Animal Health (known as MSD Animal Health outside the United States and Canada) and Harrisvaccines, Inc., today announced the companies have entered into an agreement under which Merck Animal Health will acquire Harrisvaccines, a privately-held company that develops, manufactures and sells vaccines for food production and companion animals.
As a leader in biologics, Merck Animal Health has built a robust portfolio of vaccines across all animal species, stated Rick DeLuca, president, Merck Animal Health. Combining Harrisvaccines R&D and portfolio of products with our... More
